A carregar...
Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain
BACKGROUND: Icatibant is the only subcutaneous treatment for acute Type I and Type II hereditary angioedema with C1-esterase inhibitor deficiency (HAE-C1-INH) licensed for self-administration in Europe. AIM: To compare the economic impact of two icatibant administration strategies: health profession...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3584739/ https://ncbi.nlm.nih.gov/pubmed/23398817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2191-1991-3-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|